AN AUTONOMOUS ANTIBODY-BASED THERAPEUTIC STRATEGY FOR OVARIAN CANCER WITH ADDED IMMUNE ACTIVATING FUNCTION

$1,072,227FY2019Defense Health AgencyDOD

University Of California, Davis

Investigators